Roxithromycin : a solubility and stability study / Elzet van Niekerk
Roxithromycin is a semi-synthetic, macrolide antibiotic, derived from erythromycin A. It acts as a bacteriostatic drug at low concentrations and a bactericidal drug at high concentrations. It binds to the 50S subunit of the 70S ribosome, which causes the reversible inhibition of RNA-dependent bacter...
Main Author: | Van Niekerk, Elzet |
---|---|
Language: | en |
Published: |
North-West University
2013
|
Subjects: | |
Online Access: | http://hdl.handle.net/10394/8390 |
Similar Items
-
Roxithromycin : a solubility and stability study / Elzet van Niekerk
by: Van Niekerk, Elzet
Published: (2013) -
Roxithromycin monotherapy inducing a partial response in a patient with myeloma: a case report
by: Kern Y. Chai, et al.
Published: (2018-05-01) -
Impact of pharmaceutical dosage form on stability and dissolution of roxithromycin
by: Ostrowski Michał, et al.
Published: (2010-02-01) -
The use of roxithromycin in the treatment of acute bacterial rhinosinusitis
by: A. A. Krivopalov, et al.
Published: (2019-01-01) -
Roxithromycin-induced autoimmune hepatitis: a case report
by: SHENG Jianhui
Published: (2018-05-01)